Kilitch Historical Balance Sheet

KILITCH Stock

362.60 20.85 6.10%

Trend analysis of Kilitch Drugs Limited balance sheet accounts such as Total Current Liabilities of 369.3 M provides information on Kilitch Drugs' total assets, liabilities, and equity, which is the actual value of Kilitch Drugs Limited to its prevalent stockholders. By breaking down trends over time using Kilitch Drugs balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Kilitch Drugs Limited latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Kilitch Drugs Limited is a good buy for the upcoming year.

Kilitch Drugs Inventory

49.7 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kilitch Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Kilitch Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Kilitch Drugs Limited at a specified time, usually calculated after every quarter, six months, or one year. Kilitch Drugs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Kilitch Drugs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Kilitch currently owns. An asset can also be divided into two categories, current and non-current.

Kilitch Drugs Balance Sheet Chart

As of now, Kilitch Drugs' Other Stockholder Equity is increasing as compared to previous years. The Kilitch Drugs' current Accumulated Other Comprehensive Income is estimated to increase to about 346.7 M, while Total Assets are projected to decrease to under 1.7 B.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Kilitch Drugs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Kilitch Drugs Limited books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Kilitch Drugs balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Kilitch Drugs Limited are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Kilitch Drugs' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Kilitch Drugs Limited current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kilitch Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	221.9M	316.5M	284.8M	157.8M
Total Assets	2.2B	2.4B	2.8B	1.7B

Short Long Term Debt Total Total Assets

Kilitch Drugs balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Current Deferred Revenue	Retained Earnings	Short Term Investments	Intangible Assets
Total Assets		0.73	-0.56	0.83	0.88	0.53	0.27	0.43	0.54	-0.23	0.44	0.7	0.13	-0.45	0.49	-0.18	0.62	0.68	0.81	0.54	0.82	0.71	-0.19	0.75	-0.14	-0.03
Short Long Term Debt Total	0.73		0.06	0.84	0.41	0.8	0.65	0.23	0.57	-0.54	0.04	0.7	-0.05	0.2	0.81	-0.25	0.47	0.83	0.47	0.67	0.38	0.64	0.2	0.69	0.12	-0.1
Other Current Liab	-0.56	0.06		-0.15	-0.79	0.15	0.26	-0.3	-0.22	-0.13	-0.44	-0.26	-0.2	0.98	0.14	-0.13	-0.45	0.06	-0.51	-0.13	-0.84	-0.21	0.61	-0.15	0.54	-0.08
Total Current Liabilities	0.83	0.84	-0.15		0.48	0.76	0.48	0.25	0.46	-0.24	0.35	0.58	0.26	0.0	0.47	-0.22	0.35	0.97	0.66	0.39	0.44	0.82	0.27	0.57	0.23	-0.08
Total Stockholder Equity	0.88	0.41	-0.79	0.48		0.18	0.0	0.44	0.45	-0.12	0.43	0.58	0.01	-0.74	0.33	-0.08	0.63	0.26	0.73	0.47	0.93	0.44	-0.53	0.67	-0.42	0.03
Property Plant And Equipment Net	0.53	0.8	0.15	0.76	0.18		0.57	0.08	0.72	-0.67	-0.21	0.31	-0.25	0.25	0.57	0.09	0.13	0.81	0.13	0.61	0.26	0.83	0.08	0.32	-0.01	-0.11
Net Debt	0.27	0.65	0.26	0.48	0.0	0.57		-0.55	0.45	-0.48	-0.29	0.34	-0.07	0.35	0.58	0.06	0.28	0.52	0.01	0.42	0.08	0.34	0.27	0.19	0.19	-0.04
Cash	0.43	0.23	-0.3	0.25	0.44	0.08	-0.55		0.03	0.0	0.39	0.42	0.02	-0.27	0.14	-0.37	0.34	0.17	0.48	0.29	0.34	0.22	-0.17	0.51	-0.15	-0.08
Non Current Assets Total	0.54	0.57	-0.22	0.46	0.45	0.72	0.45	0.03		-0.85	-0.48	0.32	-0.47	-0.18	0.5	0.38	0.39	0.39	-0.05	0.74	0.57	0.65	-0.42	0.27	-0.63	0.09
Non Currrent Assets Other	-0.23	-0.54	-0.13	-0.24	-0.12	-0.67	-0.48	0.0	-0.85		0.74	-0.29	0.68	-0.14	-0.57	-0.36	-0.25	-0.25	0.32	-0.8	-0.27	-0.45	0.31	-0.12	0.55	-0.11
Cash And Short Term Investments	0.44	0.04	-0.44	0.35	0.43	-0.21	-0.29	0.39	-0.48	0.74		0.2	0.7	-0.38	-0.15	-0.47	0.16	0.26	0.86	-0.33	0.28	0.08	0.21	0.37	0.47	-0.17
Net Receivables	0.7	0.7	-0.26	0.58	0.58	0.31	0.34	0.42	0.32	-0.29	0.2		-0.06	-0.16	0.5	-0.48	0.66	0.5	0.61	0.66	0.47	0.46	-0.08	0.74	-0.06	-0.02
Common Stock Shares Outstanding	0.13	-0.05	-0.2	0.26	0.01	-0.25	-0.07	0.02	-0.47	0.68	0.7	-0.06		-0.11	-0.21	-0.23	0.03	0.26	0.48	-0.65	-0.03	-0.18	0.62	-0.04	0.54	-0.09
Non Current Liabilities Total	-0.45	0.2	0.98	0.0	-0.74	0.25	0.35	-0.27	-0.18	-0.14	-0.38	-0.16	-0.11		0.22	-0.19	-0.38	0.21	-0.41	-0.09	-0.79	-0.12	0.7	-0.07	0.6	-0.11
Inventory	0.49	0.81	0.14	0.47	0.33	0.57	0.58	0.14	0.5	-0.57	-0.15	0.5	-0.21	0.22		-0.08	0.53	0.45	0.24	0.65	0.31	0.27	0.07	0.6	-0.01	-0.28
Other Current Assets	-0.18	-0.25	-0.13	-0.22	-0.08	0.09	0.06	-0.37	0.38	-0.36	-0.47	-0.48	-0.23	-0.19	-0.08		-0.15	-0.24	-0.48	0.01	0.16	-0.01	-0.32	-0.58	-0.52	0.07
Other Stockholder Equity	0.62	0.47	-0.45	0.35	0.63	0.13	0.28	0.34	0.39	-0.25	0.16	0.66	0.03	-0.38	0.53	-0.15		0.2	0.46	0.58	0.62	0.18	-0.22	0.63	-0.27	0.14
Total Liab	0.68	0.83	0.06	0.97	0.26	0.81	0.52	0.17	0.39	-0.25	0.26	0.5	0.26	0.21	0.45	-0.24	0.2		0.53	0.32	0.23	0.79	0.42	0.47	0.36	-0.08
Total Current Assets	0.81	0.47	-0.51	0.66	0.73	0.13	0.01	0.48	-0.05	0.32	0.86	0.61	0.48	-0.41	0.24	-0.48	0.46	0.53		0.13	0.58	0.39	0.07	0.7	0.27	-0.11
Short Term Debt	0.54	0.67	-0.13	0.39	0.47	0.61	0.42	0.29	0.74	-0.8	-0.33	0.66	-0.65	-0.09	0.65	0.01	0.58	0.32	0.13		0.53	0.56	-0.46	0.53	-0.45	-0.01
Common Stock	0.82	0.38	-0.84	0.44	0.93	0.26	0.08	0.34	0.57	-0.27	0.28	0.47	-0.03	-0.79	0.31	0.16	0.62	0.23	0.58	0.53		0.47	-0.59	0.46	-0.56	-0.01
Accounts Payable	0.71	0.64	-0.21	0.82	0.44	0.83	0.34	0.22	0.65	-0.45	0.08	0.46	-0.18	-0.12	0.27	-0.01	0.18	0.79	0.39	0.56	0.47		-0.15	0.38	-0.1	0.02
Current Deferred Revenue	-0.19	0.2	0.61	0.27	-0.53	0.08	0.27	-0.17	-0.42	0.31	0.21	-0.08	0.62	0.7	0.07	-0.32	-0.22	0.42	0.07	-0.46	-0.59	-0.15		-0.04	0.84	-0.16
Retained Earnings	0.75	0.69	-0.15	0.57	0.67	0.32	0.19	0.51	0.27	-0.12	0.37	0.74	-0.04	-0.07	0.6	-0.58	0.63	0.47	0.7	0.53	0.46	0.38	-0.04		0.09	-0.03
Short Term Investments	-0.14	0.12	0.54	0.23	-0.42	-0.01	0.19	-0.15	-0.63	0.55	0.47	-0.06	0.54	0.6	-0.01	-0.52	-0.27	0.36	0.27	-0.45	-0.56	-0.1	0.84	0.09		-0.22
Intangible Assets	-0.03	-0.1	-0.08	-0.08	0.03	-0.11	-0.04	-0.08	0.09	-0.11	-0.17	-0.02	-0.09	-0.11	-0.28	0.07	0.14	-0.08	-0.11	-0.01	-0.01	0.02	-0.16	-0.03	-0.22

Click cells to compare fundamentals

Kilitch Drugs Account Relationship Matchups

Kilitch Drugs balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.0B	2.1B	2.2B	2.4B	2.8B	1.7B
Short Long Term Debt Total	148.0M	204.3M	221.9M	316.5M	284.8M	157.8M
Other Current Liab	22.3M	15.8M	17.7M	16.8M	15.1M	14.3M
Total Current Liabilities	733.2M	692.8M	688.7M	642.2M	738.5M	369.3M
Total Stockholder Equity	1.3B	1.4B	1.5B	1.8B	2.0B	1.2B
Property Plant And Equipment Net	733.8M	537.5M	473.6M	481.2M	433.1M	293.0M
Net Debt	23.6M	104.2M	23.5M	127.4M	114.6M	68.2M
Cash	124.5M	100.1M	198.5M	189.1M	217.5M	228.3M
Non Current Assets Total	1.2B	957.4M	931.2M	940.7M	1.1B	749.4M
Non Currrent Assets Other	4.4M	(68.8M)	6.2M	7.2M	6.4M	6.1M
Cash And Short Term Investments	488.5M	572.4M	592.0M	690.2M	793.7M	474.6M
Net Receivables	(522K)	414.3M	542.9M	632.6M	569.3M	597.8M
Common Stock Shares Outstanding	15.5M	15.6M	15.6M	15.9M	14.3M	15.4M
Liabilities And Stockholders Equity	2.0B	2.1B	2.2B	2.4B	2.8B	1.7B
Non Current Liabilities Total	3.8M	2.8M	683K	1.7M	1.6M	1.5M
Inventory	35.9M	52.9M	20.4M	93.1M	83.8M	49.7M
Other Current Assets	279.3M	20.0M	28.8M	43.5M	50.0M	47.5M
Total Liab	737.0M	695.5M	689.4M	643.9M	579.5M	357.3M
Total Current Assets	803.6M	1.1B	1.3B	1.5B	1.7B	916.0M
Accumulated Other Comprehensive Income	209.1M	254.1M	274.8M	287.1M	330.2M	346.7M
Short Term Debt	148.0M	204.3M	221.9M	316.5M	363.9M	382.1M
Common Stock	154.3M	154.9M	155.8M	160.8M	184.9M	150.7M
Accounts Payable	536.5M	428.7M	408.7M	255.9M	294.3M	177.6M
Current Deferred Revenue	42.9M	58.9M	55.9M	53.1M	47.7M	59.2M
Retained Earnings	518.2M	591.8M	696.3M	842.3M	968.7M	624.5M
Short Term Investments	364.0M	472.3M	393.5M	501.1M	451.0M	378.1M
Intangible Assets	1.5M	2.3M	204.8M	4.4M	5.1M	4.9M
Other Liab	3.9M	3.8M	2.8M	683K	614.7K	584.0K
Net Tangible Assets	954.5M	1.1B	1.2B	1.3B	1.5B	1.1B
Other Assets	17.2M	19.7M	19.8M	1.0	0.9	0.86
Property Plant Equipment	383.3M	733.8M	464.0M	473.6M	544.6M	309.3M
Short Long Term Debt	148.0M	204.3M	221.9M	316.5M	363.9M	382.1M
Good Will	219.1M	210.6M	202.2M	193.8M	174.4M	189.4M
Net Invested Capital	1.4B	1.6B	1.7B	2.1B	2.4B	1.7B
Net Working Capital	70.5M	448.3M	575.3M	817.8M	940.4M	499.5M
Capital Stock	154.3M	154.9M	155.8M	160.8M	184.9M	171.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Other Information on Investing in Kilitch Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Kilitch Historical Balance Sheet

Kilitch Drugs Inventory

49.7 Million

About Kilitch Balance Sheet Analysis

Kilitch Drugs Balance Sheet Chart

Total Assets

Total Current Liabilities

Kilitch Drugs balance sheet Correlations

Kilitch Drugs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Kilitch Drugs balance sheet Accounts

Also Currently Popular

Other Information on Investing in Kilitch Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 0.98	Other Current Liab
Total Liab	+ 0.97	Total Current Liabilities
Common Stock	+ 0.93	Total Stockholder Equity
Total Stockholder Equity	+ 0.88	Total Assets
Total Current Assets	+ 0.86	Cash And Short Term Investments
Total Current Liabilities	+ 0.84	Short Long Term Debt Total

Non Currrent Assets Other	- 0.85	Non Current Assets Total
Common Stock	- 0.84	Other Current Liab
Short Term Debt	- 0.8	Non Currrent Assets Other
Common Stock	- 0.79	Non Current Liabilities Total
Total Stockholder Equity	- 0.79	Other Current Liab
Non Current Liabilities Total	- 0.74	Total Stockholder Equity